Idiopathic Pulmonary Fibrosis

March 11, 2015November 5, 2015

Novel Mobile Pulmonary Function Test Used in Free Clinic

Easy One Pro, a novel mobile pulmonary function test (PFT) developed by ndd Medical Technologies was used at a free clinic event organized by the San Antonio Pulmonary Fibrosis Support Group. The testing ... Read more

March 10, 2015November 5, 2015

IPF Patients and Caregivers Feel Emotional Burden from Illness

Idiopathic Pulmonary Fibrosis, News

Despite the lack of understanding there still is about idiopathic pulmonary fibrosis (IPF), patients who receive support and have access to resources can better overcome the obstacles related to the ... Read more

February 26, 2015November 5, 2015

Broadway Belts for PFF! Raises $150,000 for PF Research

Idiopathic Pulmonary Fibrosis, News

Several broadway artists have once again joined the Pulmonary Fibrosis Foundation’s (PFF) mission and showed off their “belting” talent in order to raise awareness and funding to support the fight against pulmonary fibrosis ... Read more

February 19, 2015November 5, 2015

Biotie’s Experimental Drug for Inflammatory, Fibrotic Pulmonary Diseases Receives Positive Feedback

Idiopathic Pulmonary Fibrosis, News

Biotie’s BTT1023 drug recently received positive feedback regarding Orphan Drug Designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA). BTT1023 is an experimental therapy indicated for ... Read more

February 16, 2015November 5, 2015

New Survey Explores Emotional And Physical Impact of IPF

Idiopathic Pulmonary Fibrosis, News

Those who live with idiopathic pulmonary fibrosis (IPF) often lack knowledge and understanding of their condition, and they tend to experience a heavy emotional burden that makes them feel that more support ... Read more

February 6, 2015November 5, 2015

iBioModulator Portfolio & Product Pipeline From Pulmonary Fibrosis, SSc Drug Developer iBio Gains Key Patent

Idiopathic Pulmonary Fibrosis, News

iBio, Inc recently announced that the company was approved for a new U.S. patent entitled “Yersinia pests Antigens, Vaccine Compositions and Related Methods.” The scope of this new patent includes plague antigens combined with the ... Read more

February 5, 2015November 5, 2015

Cynata Partners with the University of Western Australia to Boost Stem Cell Therapy for Lung Fibrosis

Idiopathic Pulmonary Fibrosis, News

On February 3, 2015, Australian stem cell and regenerative medicine company Cynata Therapeutics Ltd announced delivery testing of mesenchymal stem cells (MSCs) as a lung fibrosis treatment, addressing a market believed ... Read more

February 2, 2015November 5, 2015

University Of Alabama At Birmingham Added To The National Pulmonary Fibrosis Care Network

Idiopathic Pulmonary Fibrosis, News

The University of Alabama at Birmingham (UAB) announced that it was recently added to the Pulmonary Fibrosis Foundation’s Care Center Network. The Pulmonary Fibrosis Foundation (PFF) selected 12 new sites to be ... Read more

January 29, 2015November 5, 2015

Idiopathic Pulmonary Fibrosis Macrophage Activation in Acute Exacerbations Explored in New Study

Idiopathic Pulmonary Fibrosis, News

A new study on Acute Exacerbation of Idiopathic Pulmonary Fibrosis entitled “Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis” was published in PLOS One by Jonas Christian Schupp, part ... Read more

January 28, 2015November 5, 2015

PF Foundation Adds 12 New Sites to PFF Care Center Network

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF) has added 12 new sites to its PFF Care Center Network, which was launched in 2013 to accredit leading medical centers particularly dedicated to the diagnosis and ... Read more